Navigation Links
Zix Corporation CEO Provides Corporate Update for Second Quarter 2009
Date:7/7/2009

's ability to maintain existing and generate other revenue opportunities, including fees for scripts written or value added services for its payor customers from its PocketScript e-Prescribing business; the Company's ability to establish and maintain strategic and OEM relationships to gain customers and grow revenues, particularly in its Email Encryption business; the expected increase in competition in the Company's Email Encryption and e-Prescribing businesses; the Company's ability to successfully and timely introduce new Email Encryption and e-Prescribing products and services or related products and services and implement technological changes; and whether the Company will enter into a strategic transaction with respect to its e-Prescribing business and the effects of any such transaction on the Company and its stockholders. Further details pertaining to such risks and uncertainties may be found in the Company's public filings with the SEC. The Company does not intend, and undertakes no obligation, to update or revise any forward-looking statement, except as required by federal securities regulations.


'/>"/>
SOURCE Zix Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... New Haven Dental Group merges their practice wi...T. , (PRWEB) November 21,...partners Dr. David Gibson, Dr. Dean Cloutier, Dr. ...erged their growing practice with that of esteemed...kman decided he wanted to retire from dentistry in...
(Date:11/20/2009)...eurologist Closer to Understanding Brain Wiring an...SNewswire/ -- Dr. Jeremy Schmahmann, Professor of ...t at the Massachusetts General Hospital in Boston,...y,s research on the new field of study called "Con...n. ,, Dr. Schmahmann is an award-winning leader...
(Date:11/20/2009)..., Nov. 20 The American...ify health care reform legislation released this w...h insurance individual coverage mandate. The actua...e will minimize adverse selection stemming from mo...y the bill. ,, "The individual mandate language...
(Date:11/20/2009)...., Nov. 20 Following a recall by U...moved from sale Shedd,s Country Crock ® Side ...untry Crock ® Side Dishes DELUXE Four Cheese ..., The following code dates and UPCs are affected: ...LUXE Cheddar Broccoli Rice 21 oz, UPC 027400218316...
(Date:11/20/2009)...N.J., Nov. 20 Rates of i... peaked in late October, but the pandemic flu viru... all age groups, including the elderly, according ...(NYSE: DGX ), the world,s leading provider of di... In its most recent Quest Diagnostics Health Trend...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
... drug that might prove useful in developing treatm...ublished by Cell Press in the July 8 issue of the ...of one of the most frequently disrupted tumor supp...athological conditions. , "The cyclin kinase inhi...
...icine,attempts to treat menopausal symptoms with d...lying causes. As a result, menopausal women may ha...ugh Holistic Health Solutions, a,woman may signifi...auses,of a health problem instead of just masking ...
...E: HSP ), a global specialty pharmaceutical and m...t will host a conference call to discuss its,secon... at 8 a.m. Central,time., The company will releas...will be available on Hospira,s,Web site at http:/...
...inhibits abnormal cells, study finds , , M... in red grapes and red wine suppresses abnormal ce...ncer, according to U.S. researchers. , The compoun...e of disease, a person,s genes, and other factors....
...od Pressure, NASHVILLE, Tenn., July 7 A new arti... such as potassium, and possibly magnesium,and cal...blood pressure and,decrease blood pressure in peop...blished in a supplement appearing with the,July is...
...ire/ -- BMP Sunstone,Corporation (Nasdaq: BJGP; ,B...t it received the New Business License for BMP Sun...n investment in the People,s,Republic of China, fr...ent of Shanghai Rongheng Pharmaceutical Co.,Ltd. (...
Other Medicine News:Health News:Bacterial peptide provides new insight into common tumor suppressor 2Health News:Holistic Health Solutions Offers a Long Awaited Relief for Menopausal Symptoms 2Health News:Dietary Supplement May Prevent Breast Cancer 2Health News:Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 2Health News:Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 3Health News:BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd 2
(Date:11/20/2009)...ATICK, Mass. and LONDON, Nov. 20 /PRNewswire-First...X ) today announced that it has received 510(k) cl... (FDA) and CE Mark approval to market its WallFlex...tment of malignant esophageal strictures (obstruct... or non-resectable esophageal cancer. ,, (Phot...
(Date:11/20/2009)...NKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCall/ ... ) today announced the completion of its acquisiti... company that develops and manufactures molecular ...In May 2009, BD and HandyLab announced an exclusiv...lecular assays on the HandyLab Jaguar(TM) platform...
(Date:11/19/2009)...IRMINGHAM, Ala., Nov. 19 ...oday announced the pricing of a public offering of... share, resulting in gross proceeds of $48.75 mill...yst pursuant to an effective shelf registration st...xchange Commission. BioCryst has also granted the...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Johnson 26 Johnson to Participate in Morgan Stanley Global Healthcare Unplugged Conference 56458 1Health Expert Dr David Friedman Reveals Which Sweeteners Are Best 56456 1Health Expert Dr David Friedman Reveals Which Sweeteners Are Best 56456 2Health Expert Dr David Friedman Reveals Which Sweeteners Are Best 56456 3Anthem Blue Cross and Blue Shield in Wisconsin Harnesses Social Media to Interact with Members 56454 1Anthem Blue Cross and Blue Shield in Wisconsin Harnesses Social Media to Interact with Members 56454 2Anthem Blue Cross and Blue Shield in Wisconsin Harnesses Social Media to Interact with Members 56454 3
...ildren,s DNA, a Hint of a Mutation,s Ancestral Afr...esearchers,seeking to replicate another group,s di...ty, have further refined the signal to a particula...ifying this gene,s role in,obesity in various huma...,the gene variant, identified in DNA from African ...
...ee Recommends FDA Approve Novel Anesthesia Drug to...ithin Minutes, KENILWORTH, N.J., March 11 Scheri....S. Food and Drug Administration,(FDA) Advisory Co...ended,sugammadex for approval. After reviewing dat...e committee unanimously recommended approval of th...
Other Medicine Technology:Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 2FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 3FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent 4
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: